Abstract
Burkholderia pseudomallei is the causative agent of melioidosis, a disease that requires long-term treatment regimens with no assurance of bacterial clearance. Clinical isolates are intrinsically resistant to most antibiotics and in recent years, isolates have been collected that display resistance to frontline drugs. With the expanding global burden of B. pseudomallei, there is a need to identify new compounds or improve current treatments to reduce risk of relapse. Using the Pathogen Box generated by Medicines for Malaria Venture, we screened a library of 400 compounds for bacteriostatic or bactericidal activity against B. pseudomallei K96243 and identified seven compounds that exhibited inhibitory effects. New compounds found to have function against B. pseudomallei were auranofin, rifampicin, miltefosine, MMV688179, and MMV688271. An additional two compounds currently used to treat melioidosis, doxycycline and levofloxacin, were also identified in the screen. We determined that the minimal inhibitory concentrations (MIC) for levofloxacin, doxycycline, and MMV688271 were below 12 μg/ml for 5 strains of B. pseudomallei. To assess persister frequency, bacteria were exposed to 100x MIC of each compound. Auranofin, MMV688179, an...Continue Reading
References
Jan 5, 2000·Proceedings of the National Academy of Sciences of the United States of America·L WangW D Wilson
Sep 7, 2000·Transactions of the Royal Society of Tropical Medicine and Hygiene·B J CurrieS P Jacups
Oct 29, 2004·The Journal of Antimicrobial Chemotherapy·F M ThibaultJ-D Cavallo
Dec 8, 2005·Journal of Clinical Microbiology·Bina MaharjanSharon J Peacock
Mar 9, 2006·Health Affairs·Christopher P Adams, Van V Brantner
Oct 17, 2006·Journal of Bacteriology·Sarah JacksonWilliam T Self
Jan 1, 1948·Journal of Bacteriology·L BICHOWSKY-SLOMNITZKI
Oct 31, 2008·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Xin MingDhiren R Thakker
Mar 3, 2010·Expert Review of Anti-infective Therapy·D Mark EstesAlfredo G Torres
Jan 25, 2011·Journal of Bacteriology·Milan SrivastavaWilliam T Self
Apr 5, 2011·Journal of Medical Microbiology·Maarten FauvartJan Michiels
Oct 20, 2011·The Journal of Toxicological Sciences·Takashi AshinoTakemi Yoshida
Mar 1, 2012·PloS One·Derek S SarovichDavid M Wagner
Sep 15, 2012·Infection and Drug Resistance·Derek S SarovichTalima Pearson
Sep 17, 2013·Applied and Environmental Microbiology·Thomas K WoodBrian W Kwan
Nov 7, 2013·International Journal of Microbiology·Norazah AhmadAzura Mohd Noor
Feb 8, 2014·The Biochemical Journal·Aaron ButtRichard W Titball
Feb 24, 2015·Drugs in R&D·Christine Roder, Melanie J Thomson
Apr 2, 2015·Proceedings of the National Academy of Sciences of the United States of America·Michael B HarbutFeng Wang
May 2, 2015·Current Tropical Medicine Reports·Christopher L HatcherAlfredo G Torres
Jan 1, 2014·Emerging Microbes & Infections·Ying Zhang
Jul 5, 2015·The Journal of Antimicrobial Chemotherapy·Leire AguinagaldeJosé M Sánchez-Puelles
Feb 16, 2016·Nature Microbiology·Direk LimmathurotsakulSimon I Hay
Feb 18, 2016·PLoS Neglected Tropical Diseases·Gabriele PohligCarol A Olson
Mar 5, 2016·Scientific Reports·Shankar ThangamaniMohamed N Seleem
May 27, 2016·Microbiology Spectrum·Mariana X Byndloss, Renee M Tsolis
Jul 30, 2016·PLoS Neglected Tropical Diseases·Pornpan SuntornsutDirek Limmathurotsakul
Aug 31, 2016·Nature Microbiology·Direk LimmathurotsakulSimon I Hay
Jan 13, 2017·PLoS Neglected Tropical Diseases·Jason E Cummings, Richard A Slayden
Apr 19, 2017·Oncotarget·Hui WangMark De Ridder
May 12, 2017·PLoS Neglected Tropical Diseases·Ramar Perumal SamyLina H K Lim
Jul 19, 2017·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Babak AsghariHamzeh Mazaherylaghab
Citations
Aug 20, 2019·PLoS Neglected Tropical Diseases·Fumika Mi-IchiHiroki Yoshida
Oct 9, 2019·Expert Opinion on Biological Therapy·Daniel TapiaAlfredo G Torres
Oct 11, 2020·Scientific Reports·Brittany N RossAlfredo G Torres
Sep 26, 2020·The American Journal of Tropical Medicine and Hygiene·Anna S AmissNicole Lawrence
Nov 11, 2020·Antimicrobial Agents and Chemotherapy·Delaney BurnardPatrick N A Harris
Feb 8, 2019·Journal of Controlled Release : Official Journal of the Controlled Release Society·Riccardo V D'EliaCraig W Roberts
Mar 26, 2021·PloS One·Sam BarkerNicholas J Harmer
Nov 6, 2021·ACS Nano·Eleanor PorgesNicholas D Evans